Efforts to target tumors in vivo with high-molecular-weight plasmids have been hindered by inefficient delivery. Moreover, while siRNA and mRNA have targets in the cytosol, plasmid-based therapy must reach the nucleus to express its products. Consequently, man... ...

请注册登录后继续浏览